Noel M. Dautzenberg

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 02, 2026

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine
Published: January 23, 2026

Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas.

Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas.

Journal: Molecular therapy. Oncology
Published: June 23, 2025

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine
Published: March 05, 2025

Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL.

Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL.

Journal: Blood neoplasia
Published: May 06, 2024

Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia.

Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia.

Journal: Haematologica
Published: April 18, 2024

Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.

Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.

Journal: Journal for immunotherapy of cancer
Published: December 18, 2023

BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response.

BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response.

Journal: Nature protocols
Published: June 13, 2023

Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.

Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.

Journal: Cancers
Published: March 23, 2023

Ex vivo model unravelling cell distribution effect in hydrogels for cartilage repair.

Ex vivo model unravelling cell distribution effect in hydrogels for cartilage repair.

Journal: ALTEX
Published: April 11, 2017
Showing 1-10 of 10

Last Updated: 09/26/2026